Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 10/20 | 0.50 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.49 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | SCN1A | P35498 | 1/20 | 0.45 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.45 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | STS | P08842 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17460979 | 1.00 | ESR2 (0.50) | ESR2SERPINE1DEGS1ESR1CYP3A4 | |
| SCHEMBL777809 | 0.89 | SERPINE1 (0.58) | ESR2SERPINE1ESR1SCN1ASCN2A | |
| SCHEMBL30540804 | 0.89 | SERPINE1 (0.58) | ESR2SERPINE1ESR1SCN1ASCN2A | |
| SCHEMBL9421310 | 0.89 | SERPINE1 (0.58) | ESR2SERPINE1ESR1SCN1ASCN2A | |
| SCHEMBL19020508 | 0.85 | MAPT (0.48) | ESR2ESR1CYP2C9MAPTCA1 | |
| SCHEMBL18121566 | 0.85 | MAPT (0.48) | ESR2ESR1CYP2C9MAPTCA1 | |
| SCHEMBL24449583 | 0.85 | SCN1A (0.63) | SERPINE1SCN1ASCN2ASCN3AMAPT | |
| SCHEMBL11403407 | 0.85 | ESR2 (0.51) | ESR2SERPINE1SCN1ASCN2ASCN3A | |
| SCHEMBL13833867 | 0.85 | SERPINE1 (0.49) | ESR2SERPINE1DEGS1ESR1CYP3A4 | |
| SCHEMBL9923602 | 0.85 | SERPINE1 (0.46) | ESR2SERPINE1DEGS1ESR1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9242948-B2 | Diepoxy compound, process for producing same, and composition containing the diepoxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-01-26 | — | — | US | disclosed |
| US-9242948-B2 | Diepoxy compound, process for producing same, and composition containing the diepoxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-01-26 | — | — | US | disclosed |
| EP-2474539-B1 | DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-2474539-A1 | DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2012-07-11 | — | — | EP | disclosed |
| EP-2474539-A1 | DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120149807-A1 | DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-14 | — | — | US | disclosed |
| US-20120149807-A1 | DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-14 | — | — | US | disclosed |
| US-20120149807-A1 | DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149807-A1 | DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND | DHPS, DOHH, CYP19A1 | ESR2 460/4885SERPINE1 4384/4885DEGS1 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.